Literature DB >> 2531619

Depot medroxyprogesterone and risk of breast cancer.

R H Gray.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2531619      PMCID： PMC1837946          DOI： 10.1136/bmj.299.6707.1099-b

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  9 in total

1.  Breast cancer before age 45 and oral contraceptive use: new findings.

Authors:  D R Miller; L Rosenberg; D W Kaufman; P Stolley; M E Warshauer; S Shapiro
Journal:  Am J Epidemiol       Date:  1989-02       Impact factor: 4.897

2.  Oral contraceptive use and the risk of breast cancer in women with a "prior" history of benign breast disease.

Authors:  B V Stadel; J J Schlesselman
Journal:  Am J Epidemiol       Date:  1986-03       Impact factor: 4.897

3.  Oral contraceptives and breast cancer. A prospective cohort study.

Authors:  R J Lipnick; J E Buring; C H Hennekens; B Rosner; W Willett; C Bain; M J Stampfer; G A Colditz; R Peto; F E Speizer
Journal:  JAMA       Date:  1986-01-03       Impact factor: 56.272

Review 4.  Mammographic parenchymal patterns and breast cancer risk.

Authors:  A F Saftlas; M Szklo
Journal:  Epidemiol Rev       Date:  1987       Impact factor: 6.222

Review 5.  Cancer of the breast and reproductive tract in relation to use of oral contraceptives.

Authors:  J J Schlesselman
Journal:  Contraception       Date:  1989-07       Impact factor: 3.375

6.  Breast cancer in relation to patterns of oral contraceptive use.

Authors:  N V Harris; N S Weiss; A M Francis; L Polissar
Journal:  Am J Epidemiol       Date:  1982-10       Impact factor: 4.897

7.  Risk factors for benign breast disease.

Authors:  L A Brinton; M P Vessey; R Flavel; D Yeates
Journal:  Am J Epidemiol       Date:  1981-03       Impact factor: 4.897

8.  Depot medroxyprogesterone (Depo-Provera) and risk of breast cancer.

Authors:  C Paul; D C Skegg; G F Spears
Journal:  BMJ       Date:  1989-09-23

9.  Oral contraceptive use and breast cancer in young women. A joint national case-control study in Sweden and Norway.

Authors:  O Meirik; E Lund; H O Adami; R Bergström; T Christoffersen; P Bergsjö
Journal:  Lancet       Date:  1986-09-20       Impact factor: 79.321
  9 in total
  1 in total

1.  Progestogen-only oral contraceptives and risk of breast cancer in New Zealand.

Authors:  D C Skegg; C Paul; G F Spears; S M Williams
Journal:  Cancer Causes Control       Date:  1996-09       Impact factor: 2.506
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.